circulating markers of inflammation and endothelial dysfunction in arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity

Abdulwahab N. Al-Isa; Lukman Thalib; Abayomi O. Akanji

doi:10.1016/j.atherosclerosis.2009.07.056

circulating markers of inflammation and endothelial dysfunction in arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity

Abdulwahab N. Al-Isa, Lukman Thalib, Abayomi O. Akanji

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Original language	American English
Pages (from-to)	543-549
Number of pages	7
Journal	Atherosclerosis
Volume	208
Issue number	2
DOIs	https://doi.org/10.1016/j.atherosclerosis.2009.07.056
State	Published - 2010
Externally published	Yes

Funding Agency

Kuwait Foundation for the Advancement of Sciences

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.atherosclerosis.2009.07.056

Cite this

@article{87391eaab9504081814df29e6a19295a,

title = "circulating markers of inflammation and endothelial dysfunction in arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity",

author = "Al-Isa, \{Abdulwahab N.\} and Lukman Thalib and Akanji, \{Abayomi O.\}",

year = "2010",

doi = "10.1016/j.atherosclerosis.2009.07.056",

language = "American English",

volume = "208",

pages = "543--549",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - circulating markers of inflammation and endothelial dysfunction in arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity

AU - Al-Isa, Abdulwahab N.

AU - Thalib, Lukman

AU - Akanji, Abayomi O.

PY - 2010

Y1 - 2010

U2 - 10.1016/j.atherosclerosis.2009.07.056

DO - 10.1016/j.atherosclerosis.2009.07.056

M3 - Article

SN - 0021-9150

VL - 208

SP - 543

EP - 549

JO - Atherosclerosis

JF - Atherosclerosis

IS - 2

ER -